CSI Solar Co., Ltd. (SHA:688472)

Ligand Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10,787	11,689	18,950	11,940	7,257	8,827
Trading Asset Securities	1,904	2,035	107.58	127.71	128.76	98.24
Cash & Short-Term Investments	12,692	13,724	19,058	12,068	7,386	8,925
Cash Growth	-32.51%	-27.99%	57.92%	63.40%	-17.25%	18.21%
Accounts Receivable	10,998	12,351	8,908	8,084	4,959	3,105
Other Receivables	850.82	914.95	790	543.11	478.52	212.66
Receivables	11,849	13,266	9,698	8,627	5,438	3,318
Inventory	9,122	7,164	7,799	9,137	6,676	3,712
Prepaid Expenses	-	-	-	123.3	-	-
Other Current Assets	2,924	2,265	2,428	2,732	3,392	2,890
Total Current Assets	36,587	36,418	38,983	32,688	22,892	18,846
Property, Plant & Equipment	23,116	22,489	22,191	12,718	8,866	8,156
Long-Term Investments	1,139	1,060	916.62	462.64	380.43	289.5
Other Intangible Assets	804.35	814.94	829.02	573.76	570.01	540.89
Long-Term Accounts Receivable	-	26.57	-	-	-	-
Long-Term Deferred Tax Assets	2,586	2,213	1,564	1,147	962.02	623.99
Long-Term Deferred Charges	1,451	1,399	311.75	187.67	210.53	117.69
Other Long-Term Assets	721.95	939.77	980.57	523.56	239.41	648.08
Total Assets	66,406	65,359	65,775	48,300	34,120	29,222
Accounts Payable	11,269	10,845	12,138	16,391	9,062	7,562
Accrued Expenses	430.84	2,013	1,639	1,375	1,211	794.62
Short-Term Debt	7,600	7,963	6,887	5,273	6,125	4,009
Current Portion of Long-Term Debt	2,840	1,963	1,859	709.75	949.36	315.63
Current Portion of Leases	-	256.64	476.17	146.78	149.78	139.33
Current Income Taxes Payable	1,235	710.8	352.15	269.32	211.25	127.94
Current Unearned Revenue	3,478	2,967	5,605	3,095	1,780	1,798
Other Current Liabilities	5,560	5,156	8,133	4,834	2,645	2,109
Total Current Liabilities	32,413	31,876	37,090	32,095	22,133	16,856
Long-Term Debt	6,506	6,369	3,423	2,396	277.58	1,034
Long-Term Leases	1,717	1,434	1,208	241.11	317.29	2.72
Long-Term Unearned Revenue	1,232	1,508	1,511	1,156	1,074	748.45
Long-Term Deferred Tax Liabilities	132.87	117.43	122.27	91.1	138.22	36.23
Other Long-Term Liabilities	1,534	1,178	942.33	584.46	712.26	995.17
Total Liabilities	43,533	42,482	44,296	36,563	24,652	19,672
Common Stock	3,688	3,688	3,688	3,066	3,066	3,066
Additional Paid-In Capital	7,877	7,851	7,622	1,513	1,471	1,381
Retained Earnings	12,179	12,132	10,320	7,422	5,266	5,188
Treasury Stock	-719.94	-566.35	-	-	-	-
Comprehensive Income & Other	-124.93	-203.73	-212	-338.52	-407.23	-126.79
Total Common Equity	22,899	22,902	21,418	11,663	9,395	9,509
Minority Interest	-27.06	-24.76	61.5	73.89	73.06	40.87
Shareholders' Equity	22,872	22,877	21,480	11,737	9,468	9,550
Total Liabilities & Equity	66,406	65,359	65,775	48,300	34,120	29,222
Total Debt	18,663	17,986	13,852	8,767	7,819	5,501
Net Cash (Debt)	-5,971	-4,262	5,205	3,301	-433.47	3,424
Net Cash Growth	-	-	57.68%	-	-	-
Net Cash Per Share	-1.51	-1.16	1.52	1.07	-0.14	1.19
Filing Date Shares Outstanding	3,688	3,609	3,688	3,066	3,066	3,066
Total Common Shares Outstanding	3,688	3,688	3,688	3,066	3,066	3,066
Working Capital	4,174	4,542	1,893	592.85	758.72	1,990
Book Value Per Share	6.21	6.21	5.81	3.80	3.06	3.10
Tangible Book Value	22,095	22,087	20,589	11,089	8,825	8,968
Tangible Book Value Per Share	5.99	5.99	5.58	3.62	2.88	2.92
Land	-	237.92	198.55	193.69	116.89	132
Buildings	-	6,990	6,964	5,356	4,651	3,423
Machinery	-	19,327	17,050	10,770	9,694	8,875
Construction In Progress	-	4,145	4,266	2,503	628.71	1,298

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.